K. Hanna

发表

Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma

K. Hanna, 2019, Drugs.

Clinical strategies for optimizing infusion center care through a pandemic

K. Hanna, Ashley Barlow, Brooke Barlow, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Updates and novel treatments in urothelial carcinoma

K. Hanna, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A review of checkpoint inhibitors in the management of renal cell carcinoma

K. Hanna, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner

K. Hanna, Kelley D. Mayden, 2021, Journal of the Advanced Practitioner in Oncology.

Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding.

K. Hanna, Jarett C Worden, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia

K. Hanna, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia

K. Hanna, A. Fijalka, Ian Watson, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The role of Bruton’s tyrosine kinase inhibitors in the management of mantle cell lymphoma

K. Hanna, M. Campbell, Alex Husak, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

2020–2021 Drug Updates in Hematologic Malignancies

K. Hanna, 2022, Journal of the advanced practitioner in oncology.

Chemotherapy Treatment Considerations in Metastatic Breast Cancer

K. Hanna, Kelley D. Mayden, 2021, Journal of the advanced practitioner in oncology.

Updates in the management of relapsed/refractory multiple myeloma

K. Hanna, Jenny N. Nguyen, Samantha Larson, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer

K. Hanna, Kelley D. Mayden, 2021, Journal of the advanced practitioner in oncology.

Erdafitinib to treat urothelial carcinoma.

K. Hanna, 2019, Drugs of today.

A Review of Immune Checkpoint Inhibitors for the Management of Locally Advanced or Metastatic Urothelial Carcinoma

K. Hanna, 2017, Pharmacotherapy.

Updates in the management and future landscape of urothelial carcinoma

K. Hanna, K. Blake, D. Bello, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Advancements in Therapy for Bladder Cancer: Enfortumab Vedotin

K. Hanna, 2020, Journal of the advanced practitioner in oncology.

A Rare Case of Pembrolizumab‐Induced Uveitis in a Patient with Metastatic Melanoma

K. Hanna, 2016, Pharmacotherapy.

Enfortumab vedotin to treat urothelial carcinoma.

K. Hanna, 2020, Drugs of today.

The role of enfortumab vedotin and sacituzumab govitecan in treatment of advanced bladder cancer.

K. Hanna, Jenny N. Nguyen, Samantha Larson, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.